Company intelligence / Profile preview

BioLight Life Sciences

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

BioLight Life Sciences Ltd. is an Israeli publicly traded investment company historically focused on ophthalmology-related biotech, investing in and developing treatments for various eye conditions. The company has undergone corporate restructuring, including the divestment of its primary asset, BioSight Ltd., which focused on oncology. BioLight Life Sciences currently operates as a holding company with a more limited portfolio.

Therapeutic areas: Infectious DiseasesOphthalmology
Modalities: Small molecule
Industry: Investors

Beyond the preview

Go deeper on BioLight Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioLight Life Sciences.

Explore the full profile